Fortress Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fortress Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Fortress Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $14.2M, a 19.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $14.2M -$3.36M -19.2% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $14.6M -$3.33M -18.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $16.5M -$3.01M -15.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $17M -$3M -15% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $17.5M -$2.25M -11.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $18M -$165K -0.91% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $19.5M +$902K +4.86% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $20M +$986K +5.19% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $19.8M +$341K +1.76% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $18.1M -$1.62M -8.19% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $18.6M -$1.51M -7.51% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $19M -$1.48M -7.23% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $19.4M -$850K -4.19% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $19.7M -$944K -4.57% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $20.1M -$1M -4.76% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $20.5M -$993K -4.62% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $20.3M -$1.61M -7.36% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $20.7M -$1.58M -7.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $21.1M -$1.54M -6.82% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $21.5M +$21.5M Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $21.9M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $22.3M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $22.6M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.